Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also called COVID-19, targets the respiratory system, leading to symptoms such as cough, fever, and diffculty breathing. As the mechanisms behind SARS-CoV-2 infections continues to be studied, understanding of how this virus targets specific tissues becomes more apparent. Angiotensin-converting enzyme-2 (ACE2), the target of SARS-CoV infections and a functional receptor for SARS-CoV-2 invasions, is highly expressed in many tissues throughout the body, including the lungs, kidneys, and brain. Notably, our group previously reported that neurons are the main cells within the brain expressing ACE2. Accordingly, we hypothesized that neuronal infection of brainstem respiratory centers by SARS-CoV-2 could contribute to respiratory symptoms associated with COVID-19, specifically respiratory failure. C57BI6/J mice were mock infected or received SARS-CoV-2 (7.5x103 or 1.5x104) intranasally in a BSL-3 facility (University of Texas in Galveston) and were euthanized by CO2 hypoxia after 5 days post infection. The heads were harvested and immersed in formalin for 3 days before being transferred to LSU Health-NO for processing. Brains were carefully dissected out and preserved in optimal cutting temperature (OCT) before sectioning on a cryostat. Sections (30 μm) containing the retrotrapezoid nucleus (RTN) were selected as its neurons are part of the pontomedullary regions that generate the respiratory rhythm and pattern. Immunohistochemistry for c-Fos, a marker of neuronal activity, was used to assess neuronal activity in the RTN. Sections were incubated overnight with a primary monoclonal antibody (rabbit anti c-Fos, 1:1000) followed with a secondary goat antirabbit fluorescent IgG (GFP, 1:200, 1h) antibody. Sections were then mounted to slides in the dark to preserve the fluorescence and observed under the microscope. Images of neurons present in the RTN were captured and neurons were then hand counted and averaged. Neuronal activity in the RTN was decreased with the dose of SARS-CoV-2 used to infect cells in the brain. The greater the dose of SARS-CoV-2, the lower the number of c-Fos-positive neurons was detected in the RTN. Mock brains had the greatest number of neurons and brains infected with 1.5x104 SARS-CoV-2 had the lowest number of neurons in the RTN. This was demonstrated by counting neurons at 3 different intervals and taking the average. We conclude that SARS-CoV-2 targets neurons in respiratory centers, possibly contributing to impaired respiratory function in infected patients. NIH/NHLBI HL163814. This is the full abstract presented at the American Physiology Summit 2024 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call